Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Jones

Showing results (251-260 of 588) with videos related to

Pageof 59
Sort By:
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomasRomain Appay, Frédéric Fina, Nicolas Macagno, et al.
Acta Neuropathologica|August 4, 2022
Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusionJulie Messiaen, Annelies Claeys, Aniket Shetty, et al.
Heliyon|January 4, 2019
Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERKFiona Hey, Catherine Andreadi, Catherine Noble, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancersNil A Schubert, Caitlin D Lowery, Guillaume Bergthold, et al.
Acta Neuropathologica|August 22, 2014
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytomaFelix Sahm, David Reuss, Christian Koelsche, et al.
JCO Precision Oncology|January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug TargetsElke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
Acta Neuropathologica|August 19, 2022
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomasHelin Dogan, Christina Blume, Areeba Patel, et al.
Acta Neuropathologica|April 29, 2019
Molecular progression of SHH-activated medulloblastomasAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomasAndrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Pageof 59

Showing results (251-260 of 588) with videos related to

Sort By:
Pageof 59
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2018
Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomasRomain Appay, Frédéric Fina, Nicolas Macagno, et al.
Acta Neuropathologica|August 4, 2022
Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusionJulie Messiaen, Annelies Claeys, Aniket Shetty, et al.
Heliyon|January 4, 2019
Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERKFiona Hey, Catherine Andreadi, Catherine Noble, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancersNil A Schubert, Caitlin D Lowery, Guillaume Bergthold, et al.
Acta Neuropathologica|August 22, 2014
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytomaFelix Sahm, David Reuss, Christian Koelsche, et al.
JCO Precision Oncology|January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug TargetsElke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
Acta Neuropathologica|August 19, 2022
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomasHelin Dogan, Christina Blume, Areeba Patel, et al.
Acta Neuropathologica|April 29, 2019
Molecular progression of SHH-activated medulloblastomasAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomasAndrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Pageof 59